Novavax

FDA Authorizes Updated Protein-Based COVID Vaccine

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax.
By LAURAN NEERGAARD, AP

CDC Endorses Novavax Covid Shot For Adults

Health officials say U.S. adults who haven’t received any COVID-19 shots yet should consider the Novavax vaccine.
By Lauran Neergaard, AP

The Most Common Questions About The Novavax COVID Vaccine, Answered

How is the shot different from Pfizer, Moderna and J&J? Does it work against new variants? Here's what to know.
By 

Novavax Says Its COVID-19 Vaccine Is Highly Effective In Large Study

While demand for COVID-19 shots in the U.S. has dropped off dramatically, the need for more vaccines around the world remains critical.
By LINDA A. JOHNSON, AP

Novavax: Experimental COVID-19 Vaccine Has 96% Efficacy Rate

The Maryland-based company said Thursday that it was “very encouraged by the data” from its phase 3 clinical trial in the U.K.
By 

Novavax Says COVID-19 Vaccine 89% Effective, But Less So Against South African Variant

Though promising, the results raise concerns about vaccines’ power as the coronavirus continues to mutate.
By 

Novavax COVID-19 Vaccine Candidate Starts Final-Stage Trial In U.S.

Public health experts say more options in addition to the two vaccines now being dispensed are critical to amassing enough shots for the country.
By LAURAN NEERGAARD, AP